Tourmaline Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tourmaline Bio and other ETFs, options, and stocks.About TRML
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006.
CEOSandeep C. Kulkarni
CEOSandeep C. Kulkarni
Employees74
Employees74
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2021
Founded2021
Employees74
Employees74
TRML Key Statistics
Market cap1.23B
Market cap1.23B
Price-Earnings ratio-13.96
Price-Earnings ratio-13.96
Dividend yield—
Dividend yield—
Average volume776.71K
Average volume776.71K
High today$47.98
High today$47.98
Low today$47.97
Low today$47.97
Open price$47.97
Open price$47.97
Volume418.02K
Volume418.02K
52 Week high$48.27
52 Week high$48.27
52 Week low$11.56
52 Week low$11.56
Analyst ratings
88%
of 8 ratingsBuy
12.5%
Hold
87.5%
Sell
0%
People also own
Based on the portfolios of people who own TRML. This list is generated using Robinhood data, and it’s not a recommendation.